P-021(ABbisko Therapeutics Co Ltd)

N/A

Report date: 2025/10/24 16:35:26
NME

Base Information

Drug NameP-021(ABbisko Therapeutics Co Ltd)
Drug Alias NameP-021P021
ClassificationSmall molecules
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesABbisko Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesABbisko Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A